Skip to search formSkip to main contentSkip to account menu

secondary pulmonary hypertension

Known as: PULMONARY HYPERTENSION SECONDARY, Pulmonary hypertension, secondary, hypertension pulmonary secondary 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

secondary hypertension

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2019
Review
2019
‘Side-Mismatched’ Single Lung Transplantation Does Not Compromise the Transplant Outcomes
2017
2017
Nitric oxide: A new possible biomarker in heart failure? Relationship with pulmonary hypertension secondary to left heart failure
2013
2013
FRI0380 An indirect comparisons analysis of prostacyclins, endothelin receptor antagonists and phosphodiesterase inhibitors to evaluate for differences between the treatment for primary and secondary…
Background Differences in the pathogenesis between primary pulmonary hypertension (PpHTN) and secondary pulmonary hypertension… 
2012
2012
[Secondary pulmonary hypertension: some aspects of pathogenesis].
AIM To study morphofunctional condition of pulmonary vessels in chronic obstructive pulmonary disease (COPD) and idiopathic… 
2010
2010
Lungentransplantation bei Lungenemphysem - Wer? Wann? Wie? Lung Transplantation for Pulmonary Emphysema - Who, When, How?
End stage pulmonary emphysema is the most common indication for lung transplantation worldwide. The shortness of donor organs and… 
2007
2007
Expression and activity of cAMP phosphodiesterase isoforms in pulmonary artery smooth muscle cells from patients with pulmonary hypertension : role for PDE 1
Murray F, Patel HH, Suda RY, Zhang S, Thistlethwaite PA, Yuan JX, Insel PA. Expression and activity of cAMP phosphodiesterase… 
Review
2004
Review
2004
Pulmonary hypertension and systemic diseases.
Secondary pulmonary hypertension (sPH) may develop as a result of few systemic diseases as endocrine diseases, HIV infection… 
2004
2004
[Blockers of angiotensin receptors: a novel approach to the treatment of secondary pulmonary hypertension].
AIM To evaluate efficacy of losartan, a blocker of angiotensin receptors, in combined treatment of secondary pulmonary… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)